ZARUTATUG VEDOTIN
UNII P79E9QA5C9

Substance Identification & Data

This profile provides standardized clinical and technical data for Zarutatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P79E9QA5C9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3038456-03-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
P79E9QA5C9
CAS Registry Number
3038456-03-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ZARUTATUG VEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224805
National Cancer Institute reference terminology for clinical and research data.
INN ID
13745
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zarutatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CADHERIN 17) (HUMAN-MUS MUSCULUS MONOCLONAL TORL-3-600 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TORL-3-600 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CDH17 (CADHERIN 17)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO VEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE) (ZARUTATUG VEDOTIN)
ZARUTATUG VEDOTIN
ZARUTATUG VEDOTIN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus